Clinical Trials Directory

Trials / Completed

CompletedNCT02075138

Grass Observational Study

An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis

Status
Completed
Phase
Study type
Observational
Enrollment
109 (actual)
Sponsor
Circassia Limited · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Grass pollen allergens are universally recognised as a major cause of allergic diseases in humans, including asthma, allergic rhinitis, conjunctivitis and dermatitis. The purpose of the current study is to evaluate allergy symptoms and allergy medication in subjects with grass-related rhinoconjunctivitis.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-03-03
Last updated
2015-04-08

Locations

7 sites across 3 countries: United States, Argentina, Chile

Source: ClinicalTrials.gov record NCT02075138. Inclusion in this directory is not an endorsement.

Grass Observational Study (NCT02075138) · Clinical Trials Directory